Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AssurX has announced that oral solid dose CDMO TEDOR Pharma has selected the AssurX platform to fully automate their quality and compliance management processes.
read more
Premier Pharmacy Labs is voluntarily recalling all unexpired products, intended to be sterile, due to a lack of sterility assurance.
read more
Glenmark has received a CRL from the FDA for Ryaltris™ (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), Nasal Spray.
read more
Cambrex has announced three senior appointments to further support the Contract development and Manufacturing Organization company.
read more
The FDA has issued warning letters to three repackers of API for significant violations of current good manufacturing practice (CGMP) requirements.
read more
Pii announced the expansion of its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane.
read more
Nosopharm and Evotec announced their partnership aimed at advancing NOSO-502, to the clinical stage, as well as developing a second-generation Odilorhabdin drug candidate.
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
Onyx Scientific has made a strategic investment to position the company for a commercial API license.
read more
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year contract to provide manufacturing of five E. coli Master Cell Banks.
read more
Nexus Pharmaceuticals announced an agreement with the village of Pleasant Prairie, Wisconsin to build a sterile injectable manufacturing facility.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Passage Bio has entered into a collaboration agreement with Paragon Gene Therapy for the development of a dedicated manufacturing suite at their facility near Baltimore.
read more
Catalent held a ground breaking ceremony at its Bloomington, Indiana site to mark the start of construction on a $112 million drug product manufacturing facility.
read more
FUJIFILM Irvine Scientific announced plans to open a third manufacturing facility located in Tilburg, Netherlands.
read more